REG - Cambridge Cognition - Delayed Preliminary Results
RNS Number : 2589HCambridge Cognition Holdings PLC23 March 2020Cambridge Cognition Holdings plc
("Cambridge Cognition", the "Company" or the "Group")
Delayed Preliminary Results
Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, announces a delay in the publication of its preliminary results following guidance from the Financial Conduct Authority ("FCA").
Cambridge Cognition was ready to release its preliminary financial results for the year ended 31 December 2019 on 24 March 2020. However, the FCA has strongly requested that all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks from today's date. Whilst Cambridge Cognition as an AIM quoted company is not formally covered by this request, the Company will be observing this moratorium following advice from its auditors, Grant Thornton. Current guidance is that the Company may need to defer issuing its results for the year ended 31 December 2019 until such time as they are audited.
Further information on a revised timetable for publication of the Company's financial statements will be provided in due course.
The Company announced a trading update in respect of the year ended 31 December 2019 on 19 February 2020 and the Company anticipates no material differences to the information provided in that announcement.
Enquiries:
Cambridge Cognition Holdings plc
Tel: 01223 810 700
Matthew Stork, Chief Executive Officer
press@camcog.com
Nick Walters, Chief Financial Officer
finnCap Ltd (Nomad and Joint Broker)
Tel: 020 7220 0500
Geoff Nash/ Simon Hicks
(Corporate Finance)
Alice Lane/ Manasa Patil
(Corporate Broking)
Dowgate Capital Limited (Joint Broker)
Tel: 020 3903 7715
David Poutney/ James Serjeant
IFC Advisory Ltd (Financial PR and IR)
Tel: 020 3934 6630
Tim Metcalfe/ Graham Herring/ Zach Cohen
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDNORBUGDXSSDDGGX
Recent news on Cambridge Cognition Holdings
See all newsREG - Cambridge Cognition - Preliminary Results, Trading Update & Board Change
AnnouncementREG - Cambridge Cognition - Notice of Results
AnnouncementREG - Cambridge Cognition - COG spin-out Monument Therapeutics accesses £1.5m
AnnouncementREG - Cambridge Cognition - Total Voting Rights and Block Listing Return
AnnouncementREG - Cambridge Cognition - Formation of new Scientific Advisory Board
Announcement